February 01, 2015 2:37 AM ET

Pharmaceuticals

Company Overview of Catalent Pharma Solutions, Inc.

Company Overview

Catalent Pharma Solutions, Inc. provides development solutions and delivery technologies for drugs, biologics, and consumer health products. The company’s Development and Clinical Services segment offers manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also provides analytical chemical and cell-based testing and scientific services; respiratory products formulation and manufacturing; regulatory consulting; and bioanalytical testing for biologic products. Its Oral Technologies segment offers oral delivery technologies, including formulation, development, and manufacturing services for the oral dose forms comprising p...

14 Schoolhouse Road

Somerset, NJ 08873

United States

8,300 Employees

Phone:

732-537-6200

Fax:

732-537-6480

Key Executives for Catalent Pharma Solutions, Inc.

Chief Executive Officer
Age: 50
Chief Financial Officer
Age: 47
Senior Vice President of Global Operations
Age: 52
Group President for Development & Clinical Services Segment and Chief Executive Officer for Development & Clinical Services Segment
Age: 47
President of Oral Technologies - Modified Release Technology
Age: 48
Compensation as of Fiscal Year 2014.

Catalent Pharma Solutions, Inc. Key Developments

Catalent Pharma Solutions Expands Handling and Manufacturing Capabilities at New Jersey Facility

Catalent Pharma Solutions has announced the expansion of potent handling and manufacturing capabilities at its Somerset, New Jersey facility. Catalent has completed the expansion of facility and engineering controls for its high potency tableting and OptiMelt Hot Melt Extrusion operations in Somerset to supplement existing potent capabilities in oral solid and Zydis Fast Dissolve manufacturing. The company is now investing in additional potent containment for large scale blending, fluid bed processing, and high shear granulation, which will come online throughout the first half of 2015. The expansion creates a manufacturing Center of Excellence for potent handling across Catalent's portfolio of oral solid manufacturing solutions, which includes hot melt extrusion, high-shear and wet granulation processing, solvent-based capability, extrusion/spheronization, fluid-bed processing, Wurster coating, and compression and encapsulation. The Somerset facility is capable of handling SafeBridge Category 3 and 4, with SafeBridge certification expected in July of 2015.

Catalent Pharma Solutions and Sanofi Collaborate to Develop ADCs Using SMARTag Technology

Catalent Pharma Solutions announced that it has entered into collaboration with Sanofi -Aventis Recherche & Developpement to implement Catalent's SMARTag technology in the development of next generation antibody-drug conjugates, or ADCs. Under the agreement, Catalent will develop site-specifically modified antibody conjugates using Sanofi's proprietary antibodies. Catalent's precision protein-chemical engineering approach will enable Sanofi to evaluate site selective payload conjugation in order to enhance ADC pharmacokinetics, efficacy and safety. The collaborative work will involve teams at Sanofi, and Catalent's facility, in Emeryville, CA, which was formerly headquarters to Redwood Bioscience Inc.

Catalent Pharma Solutions, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015

Catalent Pharma Solutions, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

Similar Private Companies By Industry

Company Name Region
Viroxis Corporation United States
Keel Pharmaceuticals, Inc. United States
Arrien Pharmaceuticals, LLC United States
Global Bioenergetics Technology Inc. United States
Chiasma, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
October 2, 2014
Redwood Bioscience Inc.
Bankruptcy
September 16, 2014
SIGA Technologies, Inc.
Merger/Acquisition
March 24, 2014
Redwood Bioscience Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Catalent Pharma Solutions, Inc., please visit www.catalent.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.